[ad_1] Pfizer released a first snapshot of its Phase 3 studies for its coronavirus vaccine on Monday and said the results look promising with data suggesting it is 90% effective at preventing the virus. The company and its collaborator BioNTech may now be on track to file an emergency use …
Read More »